Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Biedermann

Showing results (71-80 of 201) with videos related to

Pageof 21
Sort By:
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2023
Childlessness in Patients with Inflammatory Bowel Disease - Data from the Prospective Multi-center Swiss IBD Cohort StudyMichael Christian Sulz, Michael Doulberis, Nicolas Fournier, et al.
Inflammatory Intestinal Diseases|April 14, 2021
Clinical Relevance of Anti-TNF Antibody Trough Levels and Anti-Drug Antibodies in Treating Inflammatory Bowel Disease PatientsIlana Reinhold, Sena Blümel, Jens Schreiner, et al.
Plos One|January 26, 2019
Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort StudyNina Roth, Luc Biedermann, Nicolas Fournier, et al.
Inflammatory Bowel Diseases|May 19, 2026
Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND studyTorsten Kucharzik, Ulf Helwig, Frank Seibold, et al.
Molecular Nutrition & Food Research|January 12, 2021
Diet and Inflammatory Bowel Disease: What Quality Standards Should Be Applied in Clinical and Laboratory Studies?Gerhard Rogler, Michael Scharl, Marianne Spalinger, et al.
Praxis|September 19, 2019
[From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases]Solvey Schüle, Diana Frey, Luc Biedermann, et al.
United European Gastroenterology Journal|November 18, 2020
Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurementsOrla Mader, Pascal Juillerat, Luc Biedermann, et al.
Scandinavian Journal of Gastroenterology|May 24, 2016
Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease CohortAdriano Alatri, Alain Schoepfer, Nicolas Fournier, et al.
Inflammatory Bowel Diseases|December 27, 2023
Systematic Literature Review: Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health IndicatorsMarla Dubinsky, Alexander Rice, Aaron Yarlas, et al.
Plos One|May 7, 2016
Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative ColitisSofia Roth, Marianne R Spalinger, Claudia Gottier, et al.
Pageof 21

Showing results (71-80 of 201) with videos related to

Sort By:
Pageof 21
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2023
Childlessness in Patients with Inflammatory Bowel Disease - Data from the Prospective Multi-center Swiss IBD Cohort StudyMichael Christian Sulz, Michael Doulberis, Nicolas Fournier, et al.
Inflammatory Intestinal Diseases|April 14, 2021
Clinical Relevance of Anti-TNF Antibody Trough Levels and Anti-Drug Antibodies in Treating Inflammatory Bowel Disease PatientsIlana Reinhold, Sena Blümel, Jens Schreiner, et al.
Plos One|January 26, 2019
Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort StudyNina Roth, Luc Biedermann, Nicolas Fournier, et al.
Inflammatory Bowel Diseases|May 19, 2026
Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND studyTorsten Kucharzik, Ulf Helwig, Frank Seibold, et al.
Molecular Nutrition & Food Research|January 12, 2021
Diet and Inflammatory Bowel Disease: What Quality Standards Should Be Applied in Clinical and Laboratory Studies?Gerhard Rogler, Michael Scharl, Marianne Spalinger, et al.
Praxis|September 19, 2019
[From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases]Solvey Schüle, Diana Frey, Luc Biedermann, et al.
United European Gastroenterology Journal|November 18, 2020
Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurementsOrla Mader, Pascal Juillerat, Luc Biedermann, et al.
Scandinavian Journal of Gastroenterology|May 24, 2016
Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease CohortAdriano Alatri, Alain Schoepfer, Nicolas Fournier, et al.
Inflammatory Bowel Diseases|December 27, 2023
Systematic Literature Review: Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health IndicatorsMarla Dubinsky, Alexander Rice, Aaron Yarlas, et al.
Plos One|May 7, 2016
Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative ColitisSofia Roth, Marianne R Spalinger, Claudia Gottier, et al.
Pageof 21